News & Press Releases

In an article published by Medtech Insight, Senior Director of ML Strategies Aaron Josephson provided commentary on a recent proposal from the U.S. Department of Health and Human Services (HHS) to review regulations every 10 years and its potential impact on the medical device industry.

In an article published by Inside Health Policy, Mintz Member Joanne Hawana and Senior Director of ML Strategies Aaron Josephson commented on calls from industry leaders for the Biden administration to consider making the U.S. Food and Drug Administration (FDA) an independent agency, separate from the U.S. Department of Health and Human Services (HHS), which they assert would be unlikely to move very far in Congress.

Senior Director of ML Strategies Aaron Josephson was quoted in POLITICO on the U.S. Department of Health and Human Services’ proposed rule that would require its agencies, including the U.S. Food and Drug Administration, to review all regulations within two years and determine if any can be cut.

An article published by Inside Health Policy featured extensive commentary from Senior Director of ML Strategies Aaron Josephson on priorities for the Senate Health, Education, Labor and Pensions (HELP) Committee following the 2020 Presidential election. Mintz Member Joanne Hawana was also quoted in the article.

In an article published by Law360, Vice President of ML Strategies Christian Fjeld was quoted on how the 2020 election could reshape the communications industry, specifically with regards to leadership on relevant congressional committees and the possibility of reform of Section 230 of the Communications Decency Act.

In an article published by Law360, Vice President of ML Strategies Christian Fjeld was quoted on lawmaker efforts to amend Section 230 of the Communications Decency Act.